Discovery of IHMT-EZH2-115 as a Potent and Selective Enhancer of Zeste Homolog 2 (EZH2) Inhibitor for the Treatment of B-Cell Lymphomas.
Zhou B, Liang X, Mei H, Qi S, Jiang Z, Wang A, Zou F, Liu Q, Liu J, Wang W, Hu C, Chen Y, Wang Z, Wang B, Wang L, Liu J, Liu Q.
Zhou B, et al. Among authors: liang x.
J Med Chem. 2021 Oct 28;64(20):15170-15188. doi: 10.1021/acs.jmedchem.1c01154. Epub 2021 Oct 19.
J Med Chem. 2021.
PMID: 34664960